SpringerLink
Log in

Role of vitamin D receptor gene polymorphisms in pancreatic cancer: a case–control study in China

  • Research Article
  • Published:
Tumor Biology

Abstract

The study was conducted to investigate the relationship between vitamin D receptor (VDR) gene rs2228570 and rs1544410 polymorphisms and pancreatic cancer (PC). Two hundred fifty-eight PC patients and 385 healthy controls were enrolled in this study. The genotypes of rs2228570 and rs1544410 were assayed using the polymerase chain reaction/restriction fragment length polymorphism (PCR-RFLP) method. Univariate and multivariate logistic regression analyses were applied to determine the association between PC-onset risk and VDR gene polymorphisms. Contingency table analysis was performed to evaluate the relationship between the gene polymorphisms and clinicopathological tumor features such as location, pathological differentiation, and the TNM classification of PC. In rs2228570, the T loci and genotypes with T allele could increase the risk of PC; in rs1544410, the G loci and genotypes AG + GG could decrease the onset risk of PC significantly. The contingency table analysis indicated that the rs2228570 polymorphisms were correlated with the pathological differentiation of PC significantly, and the rs1544410 polymorphisms were correlated with the TNM classification of PC significantly. In conclusion, the VDR gene polymorphisms were correlated with incidence, pathological differentiation, and the TNM classification of PC significantly in our study population. So, the VDR polymorphisms have important implications in the incident rate and survival rate of PC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Germany)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

    Article  PubMed  Google Scholar 

  2. Wolfgang CL, Herman JM, Laheru DA, et al. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318–48.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Greer JB, Brand RE. New developments in pancreatic cancer. Curr Gastroenterol Rep. 2011;13:131–9.

    Article  PubMed  Google Scholar 

  4. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144:1252–61.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg. 2008;393:535–45.

    Article  PubMed  Google Scholar 

  6. Haas SL, Ye W, Lohr JM. Alcohol consumption and digestive tract cancer. Curr Opin Clin Nutr Metab Care. 2012;15:457–67.

    Article  CAS  PubMed  Google Scholar 

  7. Norell SE, Ahlbom A, Erwald R, et al. Diet and pancreatic cancer: a case-control study. Am J Epidemiol. 1986;124:894–902.

    Article  CAS  PubMed  Google Scholar 

  8. Duell EJ, Lucenteforte E, Olson SH, et al. Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol. 2012;23:2964–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Zhu F, Li HR, Du GN, et al. Chronic hepatitis B virus infection and pancreatic cancer: a case-control study in southern China. Asian Pac J Cancer Prev. 2011;12:1405–8.

    PubMed  Google Scholar 

  10. Li L, Wu B, Yang LB, et al. Chronic hepatitis B virus infection and risk of pancreatic cancer: a meta-analysis. Asian Pac J Cancer Prev. 2013;14(1):275–9.

    Article  PubMed  Google Scholar 

  11. Chiang KC, Yeh CN, Hsu JT, et al. MART-10, a novel vitamin D analog, inhibits head and neck squamous carcinoma cells growth through cell cycle arrest at G0/G1 with upregulation of p21 and p27 and downregulation of telomerase. J Steroid Biochem Mol Biol. 2013;138:427–34.

    Article  CAS  PubMed  Google Scholar 

  12. Jehan F, d’Alesio A, Garabedian M. Exons and functional regions of the human vitamin D receptor gene around and within the main 1a promoter are well conserved among mammals. J Steroid Biochem Mol Biol. 2007;103(3–5):361–7.

    Article  CAS  PubMed  Google Scholar 

  13. Miyamoto K, Kesterson RA, Yamamoto H, et al. Structural organization of the human vitamin D receptor chromosomal gene and its promoter. Mol Endocrinol. 1997;11(8):1165–79.

    Article  CAS  PubMed  Google Scholar 

  14. Harries LW, Stubbins MJ, Forman D, et al. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 1997;18(4):641–4.

    Article  CAS  PubMed  Google Scholar 

  15. Arjumand W, Ahmad ST, Seth A, et al. Vitamin D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population. Tumour Biol : J Int Soc Oncodevelopmental Biol Med. 2012;33(1):23–31.

    Article  CAS  Google Scholar 

  16. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.

    Article  PubMed  Google Scholar 

  17. Malvezzi M, Bertuccio P, Levi F, et al. European cancer mortality predictions for the year 2014. Ann Oncol. 2014;25(8):1650–6.

    Article  CAS  PubMed  Google Scholar 

  18. Laheru D, Biedrzycki B, Jaffee EM. Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine. Methods Mol Biol. 2013;980:175–203.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Yadav D, Lowenfels AB. The epidemiology of pancreatitis and pancreatic cancer. Gastroenterology. 2013;144(6):1252–61.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Wagner M, Redaelli C, Lietz M, et al. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004;91(5):586–94.

    Article  CAS  PubMed  Google Scholar 

  21. Poruk KE, Firpo MA, Mulvihill SJ. Screening for pancreatic cancer. Adv Surg. 2014;48:115–36.

    Article  PubMed  Google Scholar 

  22. Bournet B, Gayral M, Torrisani J, et al. Role of endoscopic ultrasound in the molecular diagnosis of pancreatic cancer. World J Gastroenterol. 2014;20(31):10758–68.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Wong HH, Lemoine NR. Pancreatic cancer: molecular pathogenesis and new therapeutic targets. Nat Rev Gastroenterol Hepatol. 2009;6(7):412–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Chou A, Waddell N, Cowley MJ, et al. Clinical and molecular characterization of HER2 amplified-pancreatic cancer. Genome Med. 2013;5(8):78.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Giangreco AA, Dambal S, Wagner D, et al. Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model. J Steroid Biochem Mol Biol. 2014. (14)00237-4.

  26. Gündüz M, Cacına C, Toptaş B, et al. Association of vitamin D receptor gene polymorphisms with colon cancer. Genet Test Mol Biomarkers. 2012;16(9):1058–61.

    Article  PubMed  Google Scholar 

  27. Vogt DP. Pancreatic cancer: a current overview. Curr Surg. 2000;57(3):214–20.

    Article  CAS  PubMed  Google Scholar 

  28. Van Loon K, Owzar K, Jiang C, et al. 25-Hydroxyvitamin D levels and survival in advanced pancreatic cancer: findings from CALGB 80303 (Alliance). J Natl Cancer Inst. 2014; 106(8).

  29. Colston KW, James SY, Ofori-Kuragu EA, et al. Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro. Br J Cancer. 1997;76(8):1017–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Verlinden L, Verstuyf A, Van Camp M, et al. Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo. Cancer Res. 2000;60(10):2673–9.

    CAS  PubMed  Google Scholar 

  31. Campbell MJ, Elstner E, Holden S, et al. Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. J Mol Endocrinol. 1997;19(1):15–27.

    Article  CAS  PubMed  Google Scholar 

  32. Jiang YJ, Teichert AE, Fong F, et al. 1alpha,25(OH)2-dihydroxyvitamin D3/VDR protects the skin from UVB-induced tumor formation by interacting with the beta-catenin pathway. J Steroid Biochem Mol Biol. 2013;136:229–32.

    Article  CAS  PubMed  Google Scholar 

  33. Rosli SN, Shintani T, Hayashido Y, et al. 1alpha,25OH2D3 down-regulates HBp17/FGFBP-1 expression via NF-kappaB pathway. J Steroid Biochem Mol Biol. 2013;136:98–101.

    Article  CAS  PubMed  Google Scholar 

  34. DeBerardinis AM, Banerjee U, Miller M, et al. Probing the structural requirements for vitamin D3 inhibition of the hedgehog signaling pathway. Bioorg Med Chem Lett. 2012;22(14):4859–63.

    Article  CAS  PubMed  Google Scholar 

  35. Wang W, Zhao CH, Zhang N, Wang J. Vitamin D analog EB1089 induces apoptosis in a subpopulation of SGC-7901 gastric cancer cells through a mitochondrial-dependent apoptotic pathway. Nutr Cancer. 2013;65(7):1067–75.

    Article  CAS  PubMed  Google Scholar 

  36. Sherman MH, Yu RT, Engle DD, et al. Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy. Cell. 2014;159(1):80–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Zhou H, Xu C, Gu M. Vitamin D receptor (VDR) gene polymorphisms and Graves’ disease: a meta-analysis. Clin Endocrinol (Oxf). 2009;70(6):938–45.

    Article  CAS  Google Scholar 

  38. Zhou TB, Jiang ZP, Zj L, et al. Association of vitamin D receptor gene polymorphism with the risk of systemic lupus erythematosus. J Recept Signal Transduct Res. 2014;22:1–7.

    Google Scholar 

  39. van Etten E, Verlinden L, Giulietti A, et al. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol. 2007;37(2):395–405.

    Article  PubMed  Google Scholar 

  40. Cross HS. Extrarenal vitamin D hydroxylase expression and activity in normal and malignant cells: modification of expression by epigenetic mechanisms and dietary substances. Nutr Rev. 2007;65(8 Pt 2):S108–12.

    Article  PubMed  Google Scholar 

  41. Ogunkolade BW, Boucher BJ, Prahl JM, et al. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes. 2002;51(7):2294–300.

    Article  CAS  PubMed  Google Scholar 

  42. Jurutka PW, Whitfield GK, Hsieh JC, et al. Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Disord. 2001;2(2):203–16.

    Article  CAS  PubMed  Google Scholar 

  43. Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta. 2006;371(1–2):1–12.

    Article  CAS  PubMed  Google Scholar 

  44. Li L, Wu B, Yang L, et al. Association of vitamin D receptor gene polymorphisms with pancreatic cancer: a pilot study in a North China population. Oncol Lett. 2013;5(5):1731–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Liu Y, Chen W, Hu ZB, et al. Plasma vitamin D levels and vitamin D receptor polymorphisms are associated with survival of non-small cell lung cancer. Chin J Cancer Res. 2011;23(1):33–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Raimondi S, Johansson H, Maisonneuve P, et al. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis. 2009;30(7):1170–80.

    Article  CAS  PubMed  Google Scholar 

  47. Oh JJ, Byun SS, Lee SE, et al. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population. Gene. 2014;533(1):86–93.

    Article  CAS  PubMed  Google Scholar 

  48. Alimirah F, Peng X, Murillo G, et al. Functional significance of vitamin D receptor FokI polymorphism in human breast cancer cells. PLoS One. 2011;6(1):e16024.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Speer G. The role of vitamin D in the prevention and the additional therapy of cancers. Magy Onkol. 2010;54(4):303–14.

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Taian City Central Hospital, 271000, Taian, Shandong Province, China

    Lei Li, Weihui Zhang, Junshan Li & Changhui Wang

  2. Taishan Medical University, Taishan, China

    Feifei Shang

  3. Taian Health Bureau, Taian, Shandong Province, China

    Canhong Zhang

  4. Department of Oncology, Taian City Central Hospital, 271000, Taian, Shandong Province, China

    Lin Wei

Authors
  1. Lei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Feifei Shang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Weihui Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Canhong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Junshan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Changhui Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lin Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lei Li.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, L., Shang, F., Zhang, W. et al. Role of vitamin D receptor gene polymorphisms in pancreatic cancer: a case–control study in China. Tumor Biol. 36, 4707–4714 (2015). https://doi.org/10.1007/s13277-015-3119-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3119-6

Keywords

Search

Navigation